Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 117 clinical trials
At-Risk for Type 1 Diabetes Extension Study

This study is an extension of the NIH-sponsored AT-Risk (TN-10) type 1 diabetes study (NCT 01030861). Teplizumab-treated and placebo-treated participants in the NIH trial who develop clinical type 1 diabetes after the conclusion of that trial, are eligible to enroll and receive teplizumab treatment within one year of diagnosis of …

type 1 diabetes mellitus
diabetes
teplizumab
  • 0 views
  • 19 Feb, 2024
  • 5 locations
Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes

This study will evaluate the effects of 3 intra-nodal injections of GAD-alum (Diamyd), together with oral vitamin D supplementation. Safety and feasibility of the treatment will be evaluated and also effects on the immune system and on the preservation of endogenous insulin production.

diabetes
metformin
vitamin d supplementation
vitamin d
vitamins
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients

Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.

  • 0 views
  • 19 Feb, 2024
  • 1 location
UPENN Case Test Trial 2 (Do Not Make Any Changes)

UPENN Case Test Trial 2 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025
  • 1 location
UPENN Case Test Trial 4 (Do Not Make Any Changes)

UPENN Case Test Trial 4 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025
  • 1 location
UPENN Case Test Trial 5 (Do Not Make Any Changes)

UPENN Case Test Trial 5 (Do Not Make Any Changes)

  • 0 views
  • 12 Jun, 2025
  • 1 location
UPENN Case Test Trial 12 (Do Not Make Any Changes)

UPENN Case Test Trial 12 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025
UPENN Case Test Trial 13 (Do Not Make Any Changes)

UPENN Case Test Trial 13 (Do Not Make Any Changes)

  • 0 views
  • 15 May, 2025
  • 1 location
Customer Outcomes & Value Experiencing A New Monitoring Technology

To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.

blood glucose monitoring
diabetes mellitus
self monitoring
blood glucose self-monitoring
type 1 diabetes mellitus
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Cardiometabolic Effects of Rapid Glucose Excursion

The effects of rapid glucose excursions, induced by intravenous bolus application of glucose in healthy probands, on cardiometabolic and inflammatory parameters will be investigated

  • 0 views
  • 19 Feb, 2024
  • 1 location